Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Role of Nitric Oxide in the Paranasal Sinuses- "Demystifying the Aerocrine Organ"

Geetha Nair, Raghu Nandhan and Mohan Kameswaran

The functions of paranasal sinuses have recently undergone a conceptual change in literature, with emerging clinical data highlighting the sinus cavity as an ‘Aerocrine Organ’. Nitric oxide (NO) is an important mediator and
inflammatory marker in human upper airways. High concentration of Nitric oxide produced within the paranasal sinuses by the respiratory epithelium, has proved to be protective against infection or allergy induced airway
inflammation. The term ‘ aerocrine ’ illustrates the airborne transport of nitric oxide as a protective biological messenger in the human respiratory tract from the nasal passages to the respiratory alveoli. NO plays the role of a
messenger between the upper and lower respiratory tracts, reducing pulmonary vascular resistance and facilitating alveolar oxygen transfer into the bloodstream. This has revolutionized the concept of nasal breathing controlling the entire pulmonary function and oxygen uptake in the lungs. This concept has found references in many of the breathing patterns described in ancient Indian yogic practices like the ‘Praanayama and Jal-Neethi'. Nitric oxide level in the paranasal sinuses, has been established today as a bio-marker of well being of the respiratory system and has found numerous clinical applications in the diagnosis and management of upper airway inflammation. Present day research is focused on prophylactic and therapeutic administration of NO in patients with chronic respiratory diseases.

Avertissement: Ce résumé a été traduit à l'aide d'outils d'intelligence artificielle et n'a pas encore été examiné ni vérifié.